Esperance Pharmaceuticals' Series A Round

Esperance Pharmaceuticals raised a round of funding on October 16, 2006.

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.…

Articles about Esperance Pharmaceuticals' Series A Round: